We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+19.22%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$420M
AUM Growth
+$109M
Cap. Flow
+$13.8M
Cap. Flow %
3.29%
Top 10 Hldgs %
50.94%
Holding
96
New
34
Increased
16
Reduced
15
Closed
28

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$14.6M
2
GILD icon
Gilead Sciences
GILD
+$12.1M
3
GSK icon
GSK
GSK
+$9.11M
4
SNY icon
Sanofi
SNY
+$8.01M
5
MDT icon
Medtronic
MDT
+$7.28M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$18.6M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$8.58M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$7.52M
4
AVTR icon
Avantor
AVTR
+$6.99M
5
INMD icon
InMode
INMD
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 78.32%
2 Miscellaneous 21.55%
3 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
1
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$66.8M 15.91%
+1,946,800
New +$23.4M
GWPH
2
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$19.4M 4.63%
185,757
+6,043
+3% +$678K
AGN
3
DELISTED
Allergan plc
AGN
$18.5M 4.41%
96,931
-3,698
-4% -$667K
CHRS icon
4
Coherus Oncology
CHRS
$218M
$17M 4.06%
946,761
+341,976
+57% +$6.31M
MDT icon
5
Medtronic
MDT
$117B
$16.7M 3.97%
147,022
+66,320
+82% +$7.28M
HCA icon
6
HCA Healthcare
HCA
$90.5B
$16.2M 3.86%
109,599
-25,000
-19% -$3.36M
MRK icon
7
Merck
MRK
$366B
$15.4M 3.68%
+177,903
New +$14.6M
PFE icon
8
Pfizer
PFE
$159B
$14.9M 3.55%
401,441
+99,523
+33% +$3.54M
WCG
9
DELISTED
Wellcare Health Plans, Inc.
WCG
$14.8M 3.53%
44,935
-5,500
-11% -$1.65M
CVM icon
10
PUT
CEL-SCI Corp
CVM
$27.4M
$14M 3.33%
50,920
+27,733
+120% +$6.54M
GILD icon
11
Gilead Sciences
GILD
$181B
$12.1M 2.88%
+186,000
New +$12.1M
UTHR icon
12
United Therapeutics
UTHR
$22.1B
$11.7M 2.78%
132,664
+45,000
+51% +$3.96M
MOH icon
13
Molina Healthcare
MOH
$10.4B
$9.94M 2.37%
73,236
+40,746
+125% +$5.13M
GSK icon
14
GSK
GSK
$102B
$9.62M 2.29%
+163,764
New +$9.11M
MCK icon
15
McKesson
MCK
$104B
$9.47M 2.25%
68,439
+5,249
+8% +$742K
COR icon
16
Cencora
COR
$61.5B
$9.46M 2.25%
111,249
+8,146
+8% +$698K
REGN icon
17
Regeneron Pharmaceuticals
REGN
$81.8B
$9.3M 2.22%
24,776
– –
ELV icon
18
Elevance Health
ELV
$85.5B
$9.28M 2.21%
30,739
+3,454
+13% +$950K
SNY icon
19
Sanofi
SNY
$107B
$8.58M 2.04%
+170,977
New +$8.01M
BEAT
20
DELISTED
BioTelemetry, Inc.
BEAT
$7.41M 1.76%
160,015
-31,025
-16% -$1.34M
LITS
21
Lite Strategy Inc
LITS
$33.4M
$5.95M 1.42%
119,943
+107,000
+827% +$3.98M
VKTX icon
22
Viking Therapeutics
VKTX
$3.75B
$5.87M 1.4%
731,453
-23,306
-3% -$170K
IMVT icon
23
Immunovant
IMVT
$8.51B
$5.48M 1.31%
+615,400
New +$6.89M
MMSI icon
24
Merit Medical Systems
MMSI
$5.4B
$4.68M 1.12%
+150,000
New +$4.3M
ARDX icon
25
Ardelyx
ARDX
$984M
$4.67M 1.11%
+621,534
New +$3.78M
1
2 3 4

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Sio Capital Management held 96 positions worth $420M, up 35% from $310M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sio Capital Management deployed $13.8M of net new capital in Q4 2019, opening 34 new positions and adding to 16 existing holdings. Its largest new stake was Merck: 177,903 shares worth $15.4M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 90% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $8.58M trimmed.

  • Sio Capital Management's largest Q4 2019 buy was Merck: 177,903 shares worth $15.4M.
  • Sio Capital Management added most to Medtronic in Q4 2019, an estimated $7.28M increase.
  • Sio Capital Management's biggest Q4 2019 reduction was Alnylam Pharmaceuticals, cutting an estimated $8.58M.
  • Sio Capital Management fully exited Johnson & Johnson in Q4 2019, selling an estimated $18.6M.
  • Sio Capital Management's ten largest holdings make up 51% of its $420M portfolio in Q4 2019.
  • Sio Capital Management opened 34 new positions and closed 28 in Q4 2019.
  • Sio Capital Management's portfolio value rose 35% quarter-over-quarter to $420M.

Based on Sio Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.